Nachrichten zur Pfizer Inc. Aktie

Will Pfizers Non-COVID Drugs Drive Sales Again This Earnings Season?

Pfizers non-COVID drugs and contributions from new and newly acquired products are likely to have driven top-line growth in the…

5 All-Weather Dividend Stocks to Buy Right Now

Market uncertainty has become the defining characteristic of the 2025 investment landscape. Thanks to volatile trade policies, persistent inflation concerns,…

2 No-Brainer Stocks to Buy With Less Than $30

Having significant capital in the bank when investing in equities is helpful, but is by no means necessary. Even with…

Pfizer (PFE) Stock Sinks As Market Gains: What You Should Know

In the closing of the recent trading day, Pfizer (PFE) stood at $22.36, denoting a -0.78% change from the preceding…

2 High-Yield Dividend Stocks to Buy for Passive Income

Passive income is essential in retirement, but building a dependable stream isnt easy. Fortunately, top-tier dividend stocks can do the…

Whats Next for Pfizer After the Company Pulls Its Weight Loss Drug? @themotleyfool #stocks $PFE

…

Whats Next for Pfizer After the Company Pulls Its Weight Loss Drug?

The anti-obesity drug market has the potential to be massive, with multiple analysts projecting it may reach at least $100…

Pfizer Stock Before Q1 Earnings Release: To Buy or Not to Buy?

PFEs non-COVID drugs and contributions from new and newly acquired products are likely to have driven top-line growth in the…

Why Vertex Pharmaceuticals Was Such a Healthy Stock on Tuesday

Vertex Pharmaceuticals (NASDAQ: VRTX) had a fine Tuesday on the stock exchange. The biotechs shares closed the day nearly 3%…

3 Ultra-High-Yield Dividend Stocks to Buy Right Now That Are Dirt Cheap

Every cloud has a silver lining. Sometimes, they have two. Thats the case with many stocks in the current market…

A Once-in-a-Decade Opportunity: 3 Magnificent Stocks Down Between 40% and 73% to Buy Right Now

The S&P 500 has dropped 10% or more nine times since 2010, not including the current sell-off. However, the index…

3 Magnificent Stocks to Buy That Are Near 52-Week Lows

Its been a tough start to 2025 for investors amid concerns regarding the strength of the U.S. economy and uncertainties…

Pfizer Abandons Its Leading Weight Loss Candidate. Should You Sell the Stock?

Although it isnt the largest therapeutic area in the pharmaceutical industry, the market for weight loss therapies has caught fire…

Huntingtons Disease Treatment Market to Hit $2.03 Billion by 2033, Driven by Cutting-Edge Therapies

Factors driving the market include rising disease prevalence, innovative therapies, and gene-based treatment breakthroughs. Key players like H Lundbeck and…

Pfizer (PFE) Laps the Stock Market: Heres Why

Pfizer (PFE) closed the most recent trading day at $22.15, moving +0.48% from the previous trading session.…

Vaccine Stocks Rise on Growing Threat of Bird Flu Infections

The Biden administration is reportedly in talks with vaccine makers Moderna (MRNA) and Pfizer (PFE) to develop bird flu vaccines…

Pfizer: Risks Priced In, Buy The Exceptional Valuation And Yield

…

Pfizer: Tasty 7% Yield

…

Why Pfizer Stock Topped the Market on Tuesday

On Tuesday, investors continued to snap up shares of big pharmaceutical company Pfizer (NYSE: PFE). Somewhat counterintuitively, this weeks rise…

Viking Therapeutics VK2735 Candidate Likely Boosted By Pfizers Woes

…

Pfizer Aktie: GLP-1-Programm gestoppt - Aktie bleibt stabil

New York (www.aktiencheck.de) - Pfizer-Aktienanalyse von Morgan Stanley: Entwicklung von Danuglipron eingestellt Pfizer Inc. (ISIN: US7170811035, WKN: 852009, Ticker-Symbol: PFE, NYSE-Symbol: PFE)…

Is High-Yield Pfizer Stock Still a Buy After Scrapping Its Weight Loss Pill?

Pfizer (NYSE: PFE) recently reminded investors how risky the drug-development business can be. On April 14, the company told investors…

Pfizer Aktie: Es wird auf einen möglichen Zukauf spekuliert

Kulmbach (www.aktiencheck.de) - Pfizer-Aktienanalyse von "Der Aktionär": Marion Schlegel vom Anlegermagazin "Der Aktionär" nimmt die Aktie von Pfizer Inc. (ISIN: US7170811035,…

Märkte am Morgen: DAX stabil – Autowerte stark; LVMH, Stellantis, Webull, Pfizer, Palantir, Meta, Intel, Nvidia, BP

Der DAX ist stark in die neue Woche gestartet. Gestern schloss er 2,85 Prozent höher bei 20.954 Punkten. Die Märkte…

Pfizer enttäuscht – Übernahmespekulationen kochen hoch

Trotz negativer News und der anhaltenden Unsicherheit aufgrund möglicher Zelle im Medizinbereich hat die Aktie des Pharmakonzerns Pfizer am Montag…

Pfizer Buy

NEW YORK (dpa-AFX Analyser) - Das Analysehaus Jefferies hat das Kursziel für Pfizer von 34 auf 32 US-Dollar gesenkt, die…

Jefferies senkt Ziel für Pfizer auf 32 Dollar - Buy

NEW YORK (dpa-AFX Analyser) - Das Analysehaus Jefferies hat das Kursziel für Pfizer von 34 auf 32 US-Dollar gesenkt, die…

UBS stuft PFIZER INC auf Neutral

ZÜRICH (dpa-AFX Analyser) - Die Schweizer Großbank UBS hat die Einstufung für Pfizer auf "Neutral" mit einem Kursziel von 24…

Structure Therapeutics shares rise on Pfizer’s obesity drug exit By Investing.com

Structure Therapeutics shares rise on Pfizer’s obesity drug exit…

UBS belässt Pfizer auf Neutral - Ziel 24 Dollar

ZÜRICH (dpa-AFX Analyser) - Die Schweizer Großbank UBS hat die Einstufung für Pfizer auf "Neutral" mit einem Kursziel von 24…

Why Eli Lilly, Novo Nordisk, and Viking Therapeutics Stocks All Popped Today

Pfizer bows, but is not entirely out of the GLP-1 race.…

ANALYSE-FLASH: JPMorgan belässt Pfizer auf 'Neutral' - Ziel 30 Dollar

NEW YORK (dpa-AFX Broker) - Die US-Bank JPMorgan hat die Einstufung für Pfizer mit einem…

ANALYSE-FLASH: JPMorgan belässt Pfizer auf Neutral - Ziel 30 Dollar

NEW YORK (dpa-AFX Broker) - Die US-Bank JPMorgan hat die Einstufung für Pfizer mit einem Kursziel von 30 US-Dollar…

Pfizer Neutral

NEW YORK (dpa-AFX Analyser) - Die US-Bank JPMorgan hat die Einstufung für Pfizer mit einem Kursziel von 30 US-Dollar auf…

Stocks making the biggest moves premarket: Apple, Nvidia, Goldman Sachs, Pfizer and more

These are the stocks posting the largest moves in premarket trading.…

Pharmaindustrie : Leberschäden in Studie – Pfizer beendet Entwicklung von Diätmittel

Der US-Pharmakonzern muss einen weiteren Rückschlag hinnehmen und stellt die Forschung an einer Abnehmtablette ein. Damit gerät Pfizer-Chef Albert Bourla…

Pfizer scraps daily weight loss pill after liver injury in one patient

The decision to stop developing danuglipron adds to a string of setbacks in the pharmaceutical giants bid to win a…

JPMorgan belässt Pfizer auf Neutral - Ziel 30 Dollar

NEW YORK (dpa-AFX Analyser) - Die US-Bank JPMorgan hat die Einstufung für Pfizer mit einem Kursziel von 30 US-Dollar auf…

Pfizer stoppt Entwicklung von Abnehmpille nach klinischer Studie

Der US-Pharmakonzern Pfizer begräbt seine Pläne zur Entwicklung eines Abnehmpräparats namens Danuglipron. Der Aktienmarkt reagiert unbarmherzig.…

Pfizer stoppt Entwicklung von Abnehmpille - Rückschlag im umkämpften Markt

NEW YORK (dpa-AFX) - Der Pharmakonzern Pfizer hat im heißumkämpften Markt um Abnehm-Medikamente einen Rückschlag erlitten. Die Entwicklung einer…

Adipositas-Markt: Pfizer wirft das Handtuch – Novo Nordisk und Co ziehen an

Massiver Rückschlag für Pfizer: Das Unternehmen stellt die Entwicklung des bis dato größten Hoffnungsträgers zur möglichen Behandlung von Adipositas ein.…

Adipositas-Markt: Pfizer wirft das Handtuch – Novo Nordisk und Co ziehen an

Massiver Rückschlag für Pfizer: Das Unternehmen stellt die Entwicklung des bis dato größten Hoffnungsträgers zur möglichen Behandlung von Adipositas ein.…

Pfizer discontinues development of weight loss pill

Pfizer Inc (NYSE:PFE, ETR:PFE) announced it will discontinue the development of its experimental weight-loss pill, danuglipron, due to safety concerns.…

1 Deeply Undervalued Stock to Buy in the Market Correction

Pfizers (NYSE: PFE) shares have been southbound for the better part of three years, partly because it was unable to…

Pfizer: A Strategy For A Chaotic Implied Volatility

…

Pfizer (PFE) Advances But Underperforms Market: Key Facts

Pfizer (PFE) closed the most recent trading day at $21.91, moving +1.48% from the previous trading session.…

Stocks making the biggest moves premarket: Walmart, Target, Apple, Pfizer, Eli Lilly, Ford and more

These are the stocks posting the largest moves in premarket trading.…

Pfizer: Best-In-Class Dividend Yield Together With Dirt Cheap Valuation

…

3 High-Yielding Dividend Stocks Near Their 52-Week Lows to Buy Right Now

If youre a dividend investor, now can be an ideal time to go bargain-hunting. The stock market is in the…

3 Beaten-Down Stocks That Are Trading Below Their Book Values

A companys book value is equal to its total assets, less its liabilities. Book value does not consider the future…